0000899243-20-035276.txt : 20201228
0000899243-20-035276.hdr.sgml : 20201228
20201228191428
ACCESSION NUMBER: 0000899243-20-035276
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201222
FILED AS OF DATE: 20201228
DATE AS OF CHANGE: 20201228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Peters Richard
CENTRAL INDEX KEY: 0001697628
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37695
FILM NUMBER: 201419683
MAIL ADDRESS:
STREET 1: MERRIMACK PHARMACEUTICALS, INC.
STREET 2: ONE KENDALL SQUARE, SUITE B7201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: YUMANITY THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001445283
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 80 GUEST STREET
STREET 2: 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02135
BUSINESS PHONE: 617-225-0096
MAIL ADDRESS:
STREET 1: 80 GUEST STREET
STREET 2: 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02135
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140813
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC
DATE OF NAME CHANGE: 20080916
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-22
0
0001445283
YUMANITY THERAPEUTICS, INC.
YMTX
0001697628
Peters Richard
C/O YUMANITY THERAPEUTICS, INC
40 GUEST STREET, SUITE 4410
BOSTON
MA
02135
1
1
0
0
President and CEO
Stock Option (Right to Buy)
8.16
2020-12-22
4
A
0
235237
A
2029-09-08
Common Stock
235237
235237
D
On August 22, 2020, the Issuer (formerly known as Proteostasis Therapeutics, Inc.) entered into an Agreement and Plan of Merger and Reorganization, as amended on November 6, 2020, with Pangolin Merger Sub, Inc. ("Merger Sub"), Yumanity, Inc. (formerly known as Yumanity Therapeutics, Inc.) and Yumanity Holdings, LLC ("Holdings"). On December 22, 2020, Merger Sub was merged with and into Yumanity, Inc., with Yumanity, Inc. surviving as a wholly-owned subsidiary of the Issuer (the "Merger"). Immediately prior to the consummation of the Merger, Holdings was merged with and into Yumanity, Inc., with Yumanity, Inc. as the surviving entity.
25% of the shares subject to the option vested on July 10, 2020. The remaining 75% vest in equal monthly installments over the subsequent three years.
Received in the Merger in exchange for a stock option to acquire 1,115,708 shares of Yumanity, Inc. common stock for $1.72 per share.
/s/ Marie Epstein, Attorney-in-Fact
2020-12-28